Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

DeSilva, M. B., Mitchell, P. K., Klein, N. P., Dixon, B. E., Tenforde, M. W., Thompson, M. G., Naleway, A. L., Grannis, S. J., Ong, T. C., Natarajan, K., Reese, S. E., Zerbo, O., Kharbanda, A. B., Patel, P., Stenehjem, E., Raiyani, C., Irving, S. A., Fadel, W. F., Rao, S., … Gaglani, M. (2022). Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022. The Journal of Infectious Diseases, 227(8), 961–969. https://doi.org/10.1093/infdis/jiac458
Authors:
Malini B DeSilva
Patrick K Mitchell
Nicola P Klein
Brian E Dixon
Mark W Tenforde
Mark G Thompson
Allison L Naleway
Shaun J Grannis
Toan C Ong
Karthik Natarajan
Sarah E Reese
Ousseny Zerbo
Anupam B Kharbanda
Palak Patel
Edward Stenehjem
Chandni Raiyani
Stephanie A Irving
William F Fadel
Suchitra Rao
Jungmi Han
Sue Reynolds
Jonathan M Davis
Ned Lewis
Charlene McEvoy
Monica Dickerson
Kristin Dascomb
Nimish R Valvi
Michelle A Barron
Kristin Goddard
Gabriela Vazquez-Benitez
Nancy Grisel
Mufaddal Mamawala
Peter J Embi
Bruce Fireman
Inih J Essien
Eric P Griggs
Julie Arndorfer
Manjusha Gaglani
Affiliated Authors:
Karthik Natarajan
Jungmi Han
Author Keywords:
severe covid-19 outcomes
covid-19 vaccination
icu admission
delta period
omicron period
Publication Type:
Article
Unique ID:
10.1093/infdis/jiac458
PMID:
Publication Date:
Data Source:
PubMed

Record Created: